Wegovy and an Itchy Scalp: What We Know and What to Watch For

What the licensed prescribing information and post-marketing reports say

The Wegovy Summary of Product Characteristics, which documents everything formally observed during clinical development, lists injection-site reactions, nausea, and gastrointestinal symptoms as common effects. Generalised pruritus (itching) is acknowledged under skin and subcutaneous tissue disorders, though it sits in a lower-frequency category than the GI effects most people associate with semaglutide.

Post-marketing surveillance captures what happens when a medicine moves from trial conditions into routine clinical use, and itching reports (including scalp-specific ones) have come through that channel for GLP-1 medicines as a class. The NHS patient information for semaglutide notes that skin reactions including itching can occur, and the MHRA's Yellow Card scheme collects ongoing safety data from patients and clinicians, which is how signals like this get formally detected and reviewed. If you experience itching on Wegovy, reporting it there contributes to that national picture.

One practical check you can do in under a minute: look at your injection sites. Localised redness, a raised weal, or itching that starts at the site and stays there is a different finding from a scalp or whole-body itch. Noting which it is helps your prescriber work out what is going on. The Wegovy treatment overview explains the injection process and how to rotate sites properly, which can reduce localised reactions.

Hair and scalp changes during rapid weight loss

Telogen effluvium is a well-documented response to physiological stress — including significant calorie reduction and rapid weight loss. The hair follicle cycle is sensitive to nutritional shifts; when the body adapts quickly to lower energy intake, a proportion of hairs can enter the resting (telogen) phase simultaneously, leading to increased shedding and sometimes scalp dryness or sensitivity.

This is not specific to semaglutide. It has been observed after bariatric surgery, very-low-calorie diets, and any other route to fast weight reduction. In most people it is temporary, resolving within a few months once weight stabilises. Protein intake matters here, adequate protein helps maintain the follicle environment, and prescribers often discuss nutritional support alongside treatment.

For a broader look at itching and skin changes people report on Wegovy, the guide to Wegovy and itchy skin covers dermatological patterns across the body rather than the scalp specifically. And if your itching involves the eyes rather than the scalp, there is a separate discussion of Wegovy and itchy eyes that covers ocular symptoms.

The distinction matters clinically. Scalp itching without any other symptoms is often a different, lower-stakes conversation than widespread itching across the skin or mucous membranes.

When an itchy scalp could signal something that needs prompt attention

Most cases of scalp itching on Wegovy are mild and self-limiting. But itching can also be an early feature of an allergic reaction, and for a prescription medicine that is always worth taking seriously.

Signs that need same-day medical attention include: itching that spreads rapidly across the body; swelling of the face, lips, tongue or throat; hives or a raised rash; difficulty breathing; or feeling faint. These would be consistent with anaphylaxis, which is rare with semaglutide but recognised. Stop the medicine and call 999 or attend A&E immediately if these occur together.

Less dramatic but still worth reporting promptly: itching that persists for more than two or three weeks at the same intensity, or that is accompanied by a visible rash, jaundice (yellowing of the skin or whites of the eyes), or pale stools, as these could indicate a hepatic or biliary cause. Gallbladder problems are a listed side effect of GLP-1 medicines. The full discussion of semaglutide and itching covers the range of causes worth considering.

For a deeper look at the semaglutide class overall, including how the medicine works and what the clinical trial programme showed, the semaglutide information page sets out the background in plain terms.

What to do and who to tell

If your scalp itching is mild, appeared in the first week or two of starting Wegovy or after a dose increase, and is not accompanied by any of the urgent symptoms above, it is reasonable to monitor it and raise it with your prescriber at your next check-in. Keeping a simple note of when it started and whether it changes around dose day can be genuinely useful information.

If you are unsure whether your symptoms need attention now rather than later, contact your prescriber directly. At nume, a real clinician reads every message, not an automated system. You can reach the team via the contact page and the clinical team profile at our lead prescriber's page gives a sense of who is reviewing your case.

Separately, the MHRA asks that patients report suspected side effects (not just serious ones) through the Yellow Card scheme. Scalp itching associated with a prescription medicine is exactly the kind of report that informs future safety guidance.

If you have been considering Wegovy and want to understand how pricing works before you start, the Wegovy price comparison guide sets out what to look for in a private prescription cost. For anyone still exploring options across the weight-loss treatment landscape, the treatment overview explains what is licensed in the UK. When you are ready, our prescribers are available to review your consultation the same day you submit it.

Speak to our prescribers by starting your free consultation, there is no obligation, and a clinician will assess whether Wegovy is appropriate for you.